Reports - RNAi Therapy Market
HealthcareRNAi Therapy Market
RNAi Therapy Market Size and Projected Growth Through 2035 by Types (Small Molecule Interfering Ribonucleic Acid (SiRNA), Microrna (MiRNA)) by Applications (Oncology, Cardiology
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global RNAi Therapy Market - Segment Analysis
1. Overview
2. Global RNAi Therapy Market, 2020 - 2032 (USD Million)
3. Global RNAi Therapy Market - by Types
3.1. By Small Molecule Interfering Ribonucleic Acid (SiRNA)
3.2. By Microrna (MiRNA)
4. Global RNAi Therapy Market - by Applications
4.1. By Oncology
4.2. By Cardiology
5. Global RNAi Therapy Market - by region
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Latin America
5.5. Middle East & Africa
6. Market comparative analysis
Chapter 4 North America RNAi Therapy Market - Segment Analysis
1. Overview
2. North America RNAi Therapy Market, 2020 - 2032 (USD Million)
3. North America RNAi Therapy Market - by Types
3.1. By Small Molecule Interfering Ribonucleic Acid (SiRNA)
3.2. By Microrna (MiRNA)
4. North America RNAi Therapy Market - by Applications
4.1. By Oncology
4.2. By Cardiology
Chapter 5 Europe RNAi Therapy Market - Segment Analysis
1. Overview
2. Europe RNAi Therapy Market, 2020 - 2032 (USD Million)
3. Europe RNAi Therapy Market - by Types
3.1. By Small Molecule Interfering Ribonucleic Acid (SiRNA)
3.2. By Microrna (MiRNA)
4. Europe RNAi Therapy Market - by Applications
4.1. By Oncology
4.2. By Cardiology
Chapter 6 Asia Pacific RNAi Therapy Market - Segment Analysis
1. Overview
2. Asia Pacific RNAi Therapy Market, 2020 - 2032 (USD Million)
3. Asia Pacific RNAi Therapy Market - by Types
3.1. By Small Molecule Interfering Ribonucleic Acid (SiRNA)
3.2. By Microrna (MiRNA)
4. Asia Pacific RNAi Therapy Market - by Applications
4.1. By Oncology
4.2. By Cardiology
Chapter 7 Latin America RNAi Therapy Market - Segment Analysis
1. Overview
2. Latin America RNAi Therapy Market, 2020 - 2032 (USD Million)
3. Latin America RNAi Therapy Market - by Types
3.1. By Small Molecule Interfering Ribonucleic Acid (SiRNA)
3.2. By Microrna (MiRNA)
4. Latin America RNAi Therapy Market - by Applications
4.1. By Oncology
4.2. By Cardiology
Chapter 8 Middle East & Africa RNAi Therapy Market - Segment Analysis
1. Overview
2. Middle East & Africa RNAi Therapy Market, 2020 - 2032 (USD Million)
3. Middle East & Africa RNAi Therapy Market - by Types
3.1. By Small Molecule Interfering Ribonucleic Acid (SiRNA)
3.2. By Microrna (MiRNA)
4. Middle East & Africa RNAi Therapy Market - by Applications
4.1. By Oncology
4.2. By Cardiology
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Alnylam
2. Sarepta Therapeutics
3. Alnylam Pharmaceuticals
4. Moderna
5. Sanofi
6. Arcturus Therapeutics
7. Silence
8. Sirnaomics
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By